Mission Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 17-07-2024
- Paid Up Capital ₹ 0.60 M
as on 17-07-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 17-07-2024
- Revenue -14.59%
(FY 2023)
- Profit 50.37%
(FY 2023)
- Ebitda -163.18%
(FY 2023)
- Net Worth 206.97%
(FY 2023)
- Total Assets -2.19%
(FY 2023)
About Mission Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹2.50 M.
Balkrushna Talaviya and Sharda Talaviya serve as directors at the Company.
- CIN/LLPIN
U24129GJ2007PTC050218
- Company No.
050218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Mission Bio-Tech Private Limited offer?
Mission Bio-Tech Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Acaricide, Fertilizers and Soil Additives, Fertilizer, Organic Fertilizers and Manure, Fungicides, Insecticides, Biopesticides, Plant Growth Promoters, Chemical Intermediates.
Who are the key members and board of directors at Mission Bio-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balkrushna Talaviya  | Director | 14-Mar-2007 | Current |
| Sharda Talaviya | Director | 30-Mar-2009 | Current |
Financial Performance of Mission Bio-Tech.
Mission Bio-Tech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.59% decrease. The company also saw a substantial improvement in profitability, with a 50.37% increase in profit. The company's net worth Soared by an impressive increase of 206.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mission Bio-Tech?
In 2023, Mission Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 12 Jan 2011 | ₹2.50 M | Open |
How Many Employees Work at Mission Bio-Tech?
Unlock and access historical data on people associated with Mission Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mission Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mission Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
